ArticleOncotarget2018

ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer.

Karineh Petrossian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.